Delphia Therapeutics
PrivateLast Round
Series A
May 2, 2024
Total Funding Raised
$67M
Company Overview
Delphia Therapeutics is a biotechnology company that develops innovative cancer therapeutics using an activation lethality platform to target cancer-linked cell signaling pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delphia Therapeutics Comparables
Compare Delphia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nested Therapeutics | 85% | |
| Alterome Therapeutics | 81% | |
| Tango Therapeutics | 80% |
Delphia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 2, 2024 |
Delphia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Seed |
| Alexandria Venture Investments | Series A |
| Nextech Invest | Series A |
| Polaris Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Steve Kelsey, M.D. appointed to the board of directors.
- May 28, 2025
Reza Mazhari appointed as the new chief business officer.
Delphia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delphia Therapeutics's valuation, stock price, and market status.
Is Delphia a public or private company?
Delphia is a private company.
What is the current stock price of Delphia?
Delphia is a private company with no public stock price. No recent secondary market data is available.
How much is Delphia worth (valuation)?
Valuation information for Delphia is not publicly available.
Can I buy Delphia stock?
Delphia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delphia's last funding round?
Delphia's most recent funding round was Series A on May 2, 2024.
Who are the main investors in Delphia?
Key investors in Delphia include GV, Nextech Invest, Alexandria Venture Investments.
Will Delphia IPO soon?
No public IPO plans have been announced for Delphia.
How can I track Delphia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delphia's secondary market activity and sign up for updates.